Clopidogrel Impurities

Avoid consuming grapefruit or grapefruit juice as it can interfere with the metabolism of clopidogrel, reducing its effectiveness. Additionally, avoid taking nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen, as these can increase the risk of bleeding.

Clopidogrel should not be taken if you have active bleeding, such as a peptic ulcer or intracranial hemorrhage. It is also contraindicated in individuals with known hypersensitivity to clopidogrel or any of its components.

The most serious adverse effect of clopidogrel is severe bleeding, which can occur in the gastrointestinal tract or other areas of the body. Rarely, it may cause a condition called thrombotic thrombocytopenic purpura (TTP), characterized by low platelet counts and blood clots in small blood vessels.

Clopidogrel is stopped 5 days before surgery to reduce the risk of excessive bleeding during the procedure. Its antiplatelet effects can last for several days after the last dose, so discontinuing it beforehand allows platelet function to partially recover.

Clopidogrel works by inhibiting the P2Y12 adenosine diphosphate (ADP) receptor on platelets, preventing platelet activation and aggregation. This reduces the formation of blood clots, lowering the risk of heart attacks and strokes.

Clopidogrel and ticagrelor are both antiplatelet medications, but ticagrelor is generally considered to have a faster onset of action and stronger antiplatelet effects. However, clopidogrel is often preferred in patients at higher risk of bleeding or those who cannot tolerate ticagrelor. The choice between these medications depends on the patient’s clinical situation and physician recommendations.